Annals of Clinical Epidemiology
Online ISSN : 2434-4338
Validation of the Designated Allergy Hospital Survey Questionnaire for Asthma and Atopic Dermatitis: A Randomized Crossover Comparison
Naoki Kajita, Koichi Yoshida, Yuri Matsubara, Masakazu Takahashi, Kyohei Takahashi, Kenji Toyokuni, Tatsuki Fukuie, Hirokazu Kimura, Yu Kuwabara, Mai Tokunaga, Yumi Koike, Akio Tanaka, Satoshi Morioke, Yosikazu Nakamura, Yasunori Ito
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: 27015

Details
Abstract

Background Reliable estimation of allergic disease prevalence requires validated survey instruments. This study compared prevalence estimates derived from the well-established American Thoracic Society Division of Lung Diseases (ATS-DLD; asthma) and UK Working Party (UKWP; atopic dermatitis) questionnaires with those obtained using the more recently developed Designated Allergic Disease Medical Hospitals (DADMHs) questionnaire to assess agreement within the same population.

Methods:A randomized, crossover internet survey was administered to adults and children. Participants were randomly assigned to two groups to evaluate potential sequencing effects, completing the ATS-DLD or UKWP and DADMHs questionnaires in alternating order. Prevalence estimates and agreement between instruments were compared.

Results:Among 4,726 adults, the DADMHs questionnaire yielded higher prevalence of current (18.7 % vs 11.3 %) and lifetime asthma (29.2 % vs 16.2 %) and a higher remission prevalence (10.5 % vs 5.0 %) than the ATS-DLD. Among 5,019 children, it showed lower current asthma prevalence (16.4% vs 21.8%) but similar lifetime prevalence (25.2 % vs 24.9 %) and a higher remission prevalence (8.7% vs 3.1%). The UKWP questionnaire indicated consistently higher atopic dermatitis prevalence among adults (27.9 % vs 16.7 %) and children (36.1 % vs 18.5 %). Agreement between questionnaires was moderate to substantial for current and lifetime asthma, lower for remission, and moderate for current atopic dermatitis.

Conclusions:The DADMHs questionnaire demonstrated acceptable agreement with established international instruments, supporting its validity for nationwide allergy surveillance in Japan. Refinement of disease-specific definitions may further improve consistency and comparability in long-term monitoring.

Content from these authors
© 2026 Society for Clinical Epidemiology

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top